Pages
End of Life - Directory of Services
Information hub for all clinicians, carers and family members, signposting to end of life support and resources available throughout Derbyshire.
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/eol-directory-services
Butterley Ward is back at Ripley Hospital
Plans have been announced to bring Butterley Ward back to Ripley Hospital from its temporary base at Ilkeston Community Hospital after Easter, during the final week of April.
https://dchs.nhs.uk/news/date-announced-butterley-ward-move-back-ripley-hospital
Temporary consolidation of Ripley and Ilkeston Urgent Treatment Centres
https://dchs.nhs.uk/news/temporary-consolidation-ripley-and-ilkeston-urgent-treatment-centres
Tracy Allen to step down as chief executive of Derbyshire’s community NHS services
Tracy Allen has announced plans to step down as chief executive of Derbyshire Community Health Services NHS Foundation Trust in September 2024, after 13 years in the role.
https://dchs.nhs.uk/news/tracy-allen-step-down-chief-executive-derbyshires-community-nhs-services
Files
Unopposed declaration - Public – Amber Valley, Erewash and South Derbyshire .pdf
Unopposed declaration - Public – Amber Valley, Erewash and South Derbyshire
Podiatry Treatment and Wound Care Procedure with Aseptic Non Touch Technique (ANTT) (S104)
S104 - Podiatry Treatment and Wound Care Procedure with Aseptic Non Touch Technique (ANTT)
L301 - Antibiotic Side Effects, Allergic Reaction, Anaphylaxis and Extravasation Leaflet
L301 - Antibiotic Side Effects, Allergic Reaction, Anaphylaxis and Extravasation Leaflet
DCHS Organisational Strategy 2023 - 2028
54016 DCHS Organisational Strategy 2023 - 2028 Final Interactive
Clinical Harms Review Additional detail for Service Level SOP - Community Podiatry Service (S113)
This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed in order to deliver a consistent approach to: • Utilising a proactive method of risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which consider health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews for the that support the Trusts governance and assurance processes and maintains practice in line with national expectations.
A8 - Product Provision Pathway (P91)
A8 - Product Provision Pathway (P91)
Appendix 4 - Establishing a Patient’s Baseline Score (P83)
Appendix 4 - Establishing a Patient’s Baseline Score (P83)
A2 - PIFU Pathway for the clinician (S126)
PIFU Pathway for the clinician
Task Allocation within Clinical Systems and Improving Communication Flow between System Partners SOP
Task Allocation within Clinical Systems and Improving Communication Flow between System Partners SOP
Disclosure Ref 202404 - Dedicated Informatics & Communications Technology (ICT) Test Team.pdf
Freedom of Information disclosure regarding dedicated Informatics & Communications Technology (ICT) Test Team